Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;70(13):2291-303.
doi: 10.1007/s00018-012-1167-2. Epub 2012 Sep 27.

Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events

Affiliations
Review

Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events

Xiaozhou He et al. Cell Mol Life Sci. 2013 Jul.

Abstract

Hypoxic/ischemic injury remains the most dreaded cause of neurological disability and mortality. Despite the humbling experiences due to lack of promising therapy, our understanding of the complex cascades underlying the neuronal insult has led to advances in basic science research. One of the most noteworthy has been the effect of opioid receptors, especially the delta-opioid receptor (DOR), on hypoxic/ischemic neurons. Our recent studies, and those of others worldwide, present strong evidence that sheds light on DOR-mediated neuroprotection in the brain, especially in the cortex. The mechanisms of DOR neuroprotection are broadly categorized as: (1) stabilization of the ionic homeostasis, (2) inhibition of excitatory transmitter release, (3) attenuation of disrupted neuronal transmission, (4) increase in antioxidant capacity, (5) regulation of intracellular pathways-inhibition of apoptotic signals and activation of pro-survival signaling, (6) regulation of specific gene and protein expression, and (7) up-regulation of endogenous opioid release and/or DOR expression. Depending upon the severity and duration of hypoxic/ischemic insult, the release of endogenous opioids and DOR expression are regulated in response to the stress, and DOR signaling acts at multiple levels to confer neuronal tolerance to harmful insult. The phenomenon of DOR neuroprotection offers a potential clue for a promising target that may have significant clinical implications in our quest for neurotherapeutics.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Overview of the mechanisms underlying DOR neuroprotection
Fig. 2
Fig. 2
DOR effect on ionic homeostasis in hypoxic/ischemic stress. BK Ch Calcium-activated potassium channels. DOR delta-opioid receptor, TRK tyrosine kinase, Na + Ch sodium channels, Ca 2+ Ch calcium channels, NMDA Ch NMDA channels, K + Ch potassium channels. Arrows in red indicate the effect of hypoxic/ischemic effects, dashed lines indicate inhibition, and green arrows/lines indicate the survival or neuroprotective mechanisms or changes
Fig. 3
Fig. 3
DOR-mediated cellular and molecular regulation in prolonged hypoxia/ischemia. ROS reactive oxygen species or oxygen free radicals, HPC hypoxic pre-conditioning, HIF hypoxia inducible factor, EO endogenous opioids, SOD superoxide dismutase, MPTP mitochondrial permeability transition pore. Arrows in red indicate effect of hypoxic/ischemic effects; dashed lines indicate inhibition; and green arrows/lines indicate the survival or neuroprotective mechanisms or changes. Blue ovals represent components involved in the neuroprotective pathways while red hexagons represent components playing role in the hypoxic/ischemic cell injury

References

    1. Hertz L. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology. 2008;55:289–309. doi: 10.1016/j.neuropharm.2008.05.023. - DOI - PubMed
    1. Yamagata K. Pathological alterations of astrocytes in stroke-prone spontaneously hypertensive rats under ischemic conditions. Neurochem Int. 2012;60:91–98. doi: 10.1016/j.neuint.2011.11.002. - DOI - PubMed
    1. Kahle KT, Simard JM, Staley KJ, Nahed BV, Jones PS, Sun D. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology. 2009;24:257–265. doi: 10.1152/physiol.00015.2009. - DOI - PubMed
    1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–e215. doi: 10.1161/CIRCULATIONAHA.109.192667. - DOI - PubMed
    1. Stankowski JN, Gupta R. Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation? Antioxid Redox Signal. 2011;14:1841–1851. doi: 10.1089/ars.2010.3292. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances